Products

What will AGI do for Bisoxatin?

This classification denotes an oxazine with the molecular formula C20H15NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7C75N0L7FP, chemically known as 2,2-bis(p-hydroxyphenyl)-3-oxo-dihydrobenzoxazin-(1,4) but generally known as bisoxatin, which bears US NIH Compound Identifier 28689. bisoxatin most often comes in base and acetate forms. European Medicines Agency schedules Bisoxatin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05856MIG. World Health Organization schedules bisoxatin in its Anatomical Therapeutic Chemical (ATC) Classification. BISOXATIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bisoxatin under HS 29349990 and SITC 51579. As of Q4 2014, BISOXATIN remains the US FDA Preferred Term for this commodity. SMILES: O1C(C2CCC(O)CC2)(C2CCC(O)CC2)C(=O)NC2C1CCCC2.

How AGI delivers it

Four ways AGI delivers for Bisoxatin

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Bisoxatin, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Bisoxatin, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Bisoxatin connects

measured by

  • Compound Puritymodel
  • Loss On Dryingmodel
  • Residual Solventmodel